The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease

Journal of Hepatology

Volumn 59, Issue 1, 2013, Pages 138-143

  Ryan, Marno C ^a   Itsiopoulos, Catherine ^a,c   Thodis, Tania ^a,c   Ward, Glenn ^a   Trost, Nicholas ^a   Hofferberth, Sophie ^a   O'Dea, Kerin ^a,d   Desmond, Paul V ^a   Johnson, Nathan A ^b   Wilson, Andrew M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Cardiovascular risk; Diet; Fatty acids; Insulin resistance; Liver fat

Indexed keywords

GLUCOSE; INSULIN; MONOUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; FAT CONTENT; FATTY LIVER; FEMALE; FOOD PROCESSING; GOLD STANDARD; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTERVENTION STUDY; MALE; MEDITERRANEAN DIET; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PEDOMETER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; AGED; CROSS-OVER STUDIES; DIET, MEDITERRANEAN; FATTY LIVER; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PILOT PROJECTS;

EID: 84879136876     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.02.012     Document Type: Article

References (46)

1. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
2. A. Afzali, K. Berry, and G.N. Ioannou Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States Liver Transpl 18 2011 29 37
3. S. Zelber-Sagi, D. Nitzan-Kaluski, Z. Halpern, and R. Oren Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures Liver Int 26 2006 856 863
4. L.S. Szczepaniak, P. Nurenberg, D. Leonard, J.D. Browning, J.S. Reingold, and S. Grundy Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population Am J Physiol Endocrinol Metab 288 2005 E462 E468
5. B.A. Neuschwander-Tetri Nonalcoholic steatohepatitis and the metabolic syndrome Am J Med Sci 330 2005 326 335
6. R. Lomonaco, C. Ortiz-Lopez, B. Orsak, A. Webb, J. Hardies, and C. Darland Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease Hepatology 55 2012 1389 1397
7. P. Angulo, J.M. Hui, G. Marchesini, E. Bugianesi, J. George, and G.C. Farrell The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854
8. G. Marchesini, M. Brizi, A.M. Morselli-Labate, G. Bianchi, E. Bugianesi, and A.J. McCullough Association of nonalcoholic fatty liver disease with insulin resistance Am J Med 107 1999 450 455
9. M.C. Ryan, A.M. Wilson, J. Slavin, J.D. Best, A.J. Jenkins, and P.V. Desmond Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease Diabetes Care 28 2005 1222 1224
10. N. Assy, G. Nasser, I. Kamayse, W. Nseir, Z. Beniashvili, and A. Djibre Soft drink consumption linked with fatty liver in the absence of traditional risk factors Can J Gastroenterol 22 2008 811 816
11. A. Fraser, R. Abel, D.A. Lawlor, D. Fraser, and A. Elhayany A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: results of a quasi-randomised controlled trial Diabetologia 51 2008 1616 1622
12. H.M. Parker, N.A. Johnson, C.A. Burdon, J.S. Cohn, H.T. O'Connor, and J. George Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis J Hepatol 56 2012 944 951
13. M. De Lorgeril, P. Salen, J.L. Martin, N. Mamelle, I. Monjaud, and P. Touboul Effect of a mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments J Am Coll Cardiol 28 1996 1103 1108
14. A. Elhayany, A. Lustman, R. Abel, J. Attal-Singer, and S. Vinker A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study Diabetes Obes Metab 12 2010 204 209
15. K. Esposito, M.I. Maiorino, A. Ceriello, and D. Giugliano Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review Diabetes Res Clin Pract 89 2010 97 102
16. F. Sofi, F. Cesari, R. Abbate, G.F. Gensini, and A. Casini Adherence to Mediterranean diet and health status: meta-analysis BMJ 337 2008 a1344
17. A. Trichopoulou, T. Costacou, C. Bamia, and D. Trichopoulos Adherence to a Mediterranean diet and survival in a Greek population N Engl J Med 348 2003 2599 2608
18. F. Sofi, R. Abbate, G.F. Gensini, and A. Casini Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis Am J Clin Nutr 92 2010 1189 1196
19. A. Elhayany, A. Lustman, R. Abel, J. Attal-Singer, and S. Vinker A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study Diabetes Obes Metab 12 2010 204 209
20. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
21. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
22. A.M. Zivkovic, J.B. German, and A.J. Sanyal Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease Am J Clin Nutr 86 2007 285 300
23. A. Keys, A. Menotti, M.J. Karvonen, C. Aravanis, H. Blackburn, and R. Buzina The diet and 15-year death rate in the seven countries study Am J Epidemiol 124 1986 903 915
24. D. Kromhout, A. Keys, C. Aravanis, R. Buzina, F. Fidanza, and S. Giampaoli Food consumption patterns in the 1960s in seven countries Am J Clin Nutr 49 1989 889 894
25. N. Psilanakis, and M. Psilanakis Cretan cooking: the miracle of the Cretan diet 1965 Karmanor, Greece Crete, Greece
26. C. Itsiopoulos, L. Brazionis, M. Kaimakamis, M. Cameron, J.D. Best, and K. O'Dea Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study Nutr Metab Cardiovasc Dis 21 2011 740 747
27. A.M. Hodge, D.R. English, C. Itsiopoulos, K. O'Dea, and G.G. Giles Does a Mediterranean diet reduce the mortality risk associated with diabetes: evidence from the Melbourne Collaborative Cohort Study Nutr Metab Cardiovasc Dis 21 2011 733 739
28. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223
29. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
30. B.H. Goodpaster, J. He, S. Watkins, and D.E. Kelley Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes J Clin Endocrinol Metab 86 2001 5755 5761
31. N.A. Johnson, S.R. Stannard, K. Mehalski, M.I. Trenell, T. Sachinwalla, and C.H. Thompson Intramyocellular triacylglycerol in prolonged cycling with high- and low-carbohydrate availability J Appl Physiol 94 2003 1365 1372
32. N.A. Johnson, T. Sachinwalla, D.W. Walton, K. Smith, A. Armstrong, and M.W. Thompson Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss Hepatology 50 2009 1105 1112
33. N.A. Johnson, D.W. Walton, T. Sachinwalla, C.H. Thompson, K. Smith, and P.A. Ruell Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders Hepatology 47 2008 1513 1523
34. A. Niaz, Z. Ali, S. Nayyar, and N. Fatima Prevalence of NAFLD in healthy and young male individuals ISRN Gastroenterol 2011 363546
35. G. Musso, R. Gambino, M. Cassader, and G. Pagano A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease Hepatology 52 2012 79 104
36. G. Musso, M. Cassader, F. Rosina, and R. Gambino Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials Diabetologia 55 2012 885 904
37. M.J. Franz, J.J. VanWormer, A.L. Crain, J.L. Boucher, T. Histon, and W. Caplan Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up J Am Diet Assoc 107 2007 1755 1767
38. P. Sumithran, L.A. Prendergast, E. Delbridge, K. Purcell, A. Shulkes, and A. Kriketos Long-term persistence of hormonal adaptations to weight loss N Engl J Med 365 2011 1597 1604
39. T.T. Fung, M. McCullough, R.M. van Dam, and F.B. Hu A prospective study of overall diet quality and risk of type 2 diabetes in women Diabetes Care 30 2007 1753 1757
40. J.A. Paniagua, A.G. de la Sacristana, E. Sanchez, I. Romero, A. Vidal-Puig, and F.J. Berral A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects J Am Coll Nutr 26 2007 434 444
41. L. Schwingshackl, B. Strasser, and G. Hoffmann Effects of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism: a systematic review and meta-analysis Ann Nutr Metab 58 2011 290 296
42. N. Assy, F. Nassar, G. Nasser, and M. Grosovski Olive oil consumption and non-alcoholic fatty liver disease World J Gastroenterol 15 2009 1809 1815
43. Carlsson AC, Wandell PE, Gigante B, Leander K, Hellenius ML, de Faire U. Seven modifiable lifestyle factors predict reduced risk for ischemic cardiovascular disease and all-cause mortality regardless of body mass index: a cohort study. Int J Cardiol. 2012. http://dx.doi.org/10.1016/j.ijcard.2012.10. 045 [Epub ahead of print].
44. P. Mofrad, M.J. Contos, M. Haque, C. Sargeant, R.A. Fisher, and V.A. Luketic Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values Hepatology 37 2003 1286 1292
45. A.L. Fracanzani, L. Valenti, E. Bugianesi, M. Andreoletti, A. Colli, and E. Vanni Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes Hepatology 48 2008 792 798
46. Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF. Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol; 16: 1560-1566.